A thought-leadership discussion exploring the rapid clinical expansion of GLP-1 receptor agonist therapies, the shifting coverage landscape across Medicare, Medicaid, and commercial payers, and the growing role of pharmacist-led utilization management in supporting appropriate access and consistent evidence-based decision-making. Our experts share insights into the financial implications for health plans and PBMs and practical strategies for evidence-based clinical decision-making.
Featuring:
Reema Hammoud, PharmD, BCPS, Director of Clinical Strategy, ExamWorks UM Strategies
Madison Mizer, PharmD, Pharmacist Manager, ExamWorks UM Strategies
Marie Pankey, PharmD, Lead Pharmacist, ExamWorks UM Strategies
This webinar provides a comprehensive overview of expanding GLP-1 indications across type 2 diabetes, obesity, cardiovascular risk reduction, and obstructive sleep apnea, along with the clinical evidence supporting their broader adoption. You'll gain critical insights into the financial implications of shifting formulary policies for health plans and PBMs and learn practical strategies for pharmacist-led utilization management programs that promote appropriate therapy, improve consistency in clinical decision-making, and balance patient outcomes with responsible cost stewardship.
Access the webinar by completing the form below: